Target intelligence / Profile preview

ZNF567 divergent transcript (ZNF567-DT)

Target
ZNF567-DT
Molecular classification
Long noncoding RNA (lncRNA), Other
01

Overview

ZNF567 divergent transcript (ZNF567-DT), also known as LINC01534, is a long noncoding RNA (lncRNA) that does not encode protein but has regulatory roles in gene expression and cell physiology. It has been shown to maintain cancer cell stemness by suppressing the endoplasmic reticulum (ER) stress response, particularly through the PERK/eIF2α signaling pathway, in colorectal cancer. High levels of ZNF567-DT expression are correlated with increased tumor cell proliferation, invasion, cell cycle progression, and reduced apoptosis, and are associated with a poor prognosis in colorectal cancer patients. In addition to its role in cancer, ZNF567-DT (LINC01534) regulates inflammatory responses via the NF-κB pathway, acting as a competing endogenous RNA (ceRNA) that modulates the miR-135b-5p/PTPRT axis, and is implicated in pathological inflammation seen in conditions such as aseptic loosening after hip replacement surgery. Current data do not indicate this lncRNA is a direct therapeutic target for existing drugs, nor are there known drug interactions or mechanistic inhibitor classes targeting it[2][3][4].

Other names
LINC01534
02

Biological functions

Regulation of cancer cell stemnessRegulation of endoplasmic reticulum stress responseModulation of cell proliferation, apoptosis, and cell cycleRegulation of inflammatory response (via NF-κB pathway)
03

Disease associations

Cancer (notably colorectal cancer)Inflammation (for example, in aseptic loosening after total hip replacement)Other
04

Biomarkers

High expression associated with poor prognosis in colorectal cancerPotential biomarker in endometrial precancerous lesions and endometrial cancer

Beyond the preview

Go deeper on ZNF567 divergent transcript (ZNF567-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF567 divergent transcript (ZNF567-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call